Elixir Medical lands Euro approval for DESyne BD bioabsorbable drug-eluting stent

Elixir Medical wins CE mark approval in the European Union for its DESyne BD drug-eluting stent with a fully-absorable polymer coating.

Elixir Medical won CE Mark approval in the European Union for its DESyne BD drug-eluting stent with a bioabsorbable polymer coating, the company announced this week.

Elixir's uses proprietary technology to coat the novolimus-eluting DESyne BD stent with an ultra-thin polymer coating that enables sustained drug release and degrades over 6 to 9 months, leaving behind a bare metal cobalt chromium stent.